David Kabakoff

David Kabakoff

Chairman at NEXTCURE, INC.

Net worth: 138 789 $ as of 2024-03-30

76 year
Health Technology
Commercial Services
Health Services

Profile

David joined the HealthQuest team in 2012 to leverage decades of experience as an entrepreneur in the diagnostics and biotech fields.
While a chemist by training, the companies that David has led as President, CEO or Chairman have produced billions of dollars in returns for investors and employees.
David brings over 44 years of industry experience to HealthQuest (14 of which have been in healthcare investing), and currently serves on the Board of portfolio company RareCyte, and previously served on the Boards of Lineagen (sold to Bionanogenomics), Biotheranostics (sold to Hologic) and Castle Biosciences (CSTL).
As an operator David’s successes include leading the development of some of the diagnostic industry’s most iconic products like the first yes/no color changing pregnancy test, the PSA test for prostate cancer and the rapid strep throat test, plus numerous cancer diagnostics.
He served in senior executive positions at Hybritech, was President of Dura Pharmaceuticals, CEO of Spiros Development Corp., Corvas International and co-founder/CEO of Salmedix.
Each of the products he developed succeeded because it made a large impact on the medical management of patients and David keeps a keen eye out for innovative products when he considers investments for HealthQuest.
He has served as Chairman of Trius Therapeutics (acquired by Cubist), Chairman of Cebix Inc., Chairman of Amplimmune, Inc. (acquired by AstraZeneca), and as a Director of InterMune, Inc. (acquired by Roche), Principia Biopharma (acquired by Sanofi), and Allylix, Inc. (acquired by Evolva).
David earned his BA in chemistry from Case Western Reserve University and then his PhD from Yale University.
He lives with his wife and enjoys fine wine, print collecting, skiing and golf.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-21 62,237 ( 0.22% ) 138 789 $ 2024-03-30

David Kabakoff active positions

CompaniesPositionStart
NEXTCURE, INC. Chairman 2015-11-30
Private Equity Investor 2008-12-31
Director/Board Member -
Director/Board Member -
Director/Board Member 2018-09-17
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of David Kabakoff

Former positions of David Kabakoff

CompaniesPositionEnd
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of David Kabakoff's experience

Training of David Kabakoff

Case Western Reserve University Undergraduate Degree
Yale University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kabakoff's experience

Connections

100 +

1st degree connections

30

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
CASTLE BIOSCIENCES, INC.

Health Technology

NEXTCURE, INC.

Health Technology

Private companies26

Health Technology

Corvas International, Inc.

Health Technology

Spiros Development Corp II, Inc.

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Miscellaneous

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. David Kabakoff